Onderneming Orgenesis Inc Other OTC
Aandelen
US68619K1051
Medische apparatuur, benodigdheden & distributie
Vakgebied
Verkoop per activiteit
USD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
Therapies
97,2
%
| 6 | 17,9 % | 1 | 97,2 % | -91,99% |
Octomera
12,8
%
| 35 | 97,6 % | 0 | 12,8 % | -99,81% |
Eliminations
-10,0
%
| -6 | -15,5 % | 0 | -10,0 % | -99,05% |
Verkoop per regio
USD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
Belgium
100,0
%
| 36 | 100,0 % | 1 | 100,0 % | -98,53% |
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Sarah Ferber
FOU | Founder | 70 | 05-06-08 |
Vered Caplan
CEO | Chief Executive Officer | 55 | 02-02-12 |
Victor Miller
DFI | Director of Finance/CFO | 54 | 02/01 |
Chief Tech/Sci/R&D Officer | - | 01-09-20 | |
Gerhard Bauer
PRN | Corporate Officer/Principal | - | 06-09-23 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
David Sidransky
BRD | Director/Board Member | 64 | 18-07-13 |
Vered Caplan
CEO | Chief Executive Officer | 55 | 02-02-12 |
Mario Philips
BRD | Director/Board Member | 54 | 09-01-20 |
Yaron Adler
BRD | Director/Board Member | 54 | 17-04-12 |
Guy Yachin
BRD | Director/Board Member | 55 | 02-04-12 |
Ashish Nanda
BRD | Director/Board Member | 59 | 22-02-17 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 34 666 847 | 24 404 393 ( 70,40 %) | 286 567 ( 0,8266 %) | 70,40 % |
Bedrijfsgegevens
Sector
Verkoop per activiteit
Verkoop per regio
Vaira. 1 jan. | Kapi. | |
---|---|---|
-5,51% | 181 mld. | |
+2,33% | 112 mld. | |
-3,62% | 67,92 mld. | |
+1,52% | 50,1 mld. | |
+8,06% | 44,27 mld. | |
+9,39% | 40,41 mld. | |
+23,35% | 31,95 mld. | |
+0,67% | 25,82 mld. | |
+17,27% | 25,29 mld. |